Pharma BD Deal Intelligence

Thermo Fisher Scientific Inc. / Life Technologies Corporation

2013 · Acquisition/Merger · $15.1B · Complete

Announcement Sentiment

Strongly positive

Outcome Score

Worked — the deal delivered on its rationale.

Thermo Fisher Scientific acquired Life Technologies Corporation for $76.13 per share in cash (approximately $13.6 billion equity value plus $1.5 billion in assumed net debt, totaling approximately $15.1 billion enterprise value). The deal created the world's leading life sciences tools company.

Key facts

Announced Apr 15, 2013
Closed Feb 03, 2014
Deal value $15.1B
Deal type Acquisition/Merger
Indications Genetic Analysis, Cell Biology, Protein Expression
Key assets Ion Torrent next-generation sequencing platform, Applied Biosystems qPCR instruments, Invitrogen cell biology reagents, Gibco cell culture media

See the full interactive analysis, sources & comparables →

← Browse all deals · How we score deals